Andi is a seasoned Life Sciences executive with 28 years of experience in commercialization and general management roles across public and private companies. Currently, she is the President and CEO of VMS BioMarketing, a healthcare services company focused on improving patient outcomes through technology-enabled, data-driven clinical educator platforms.

Previously, Andi spent 18 years at Eli Lilly and Company, holding leadership roles across finance, business development, corporate affairs, and brand management. She led P&L for key therapeutic areas like endocrinology, women’s health, and osteoporosis, consistently driving strong revenue growth.

Andi joined VMS in 2008 and became CEO in 2011. Under her leadership, VMS has seen double-digit growth, with strategic investments in technology and infrastructure. Her efforts have fostered an award-winning company culture recognized by Fortune and Great Place to Work.

Andi serves on the board of Rockwell Medical and advises Agent Capital. She has held board positions at Assertio Therapeutics, Zyla Life Sciences, and the Indiana Alzheimer’s Association.

Andi holds a BA in economics from DePauw University, where she was an Honors Management Fellow.